Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
VTYX holding history
Ventyx Biosciences, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTYX overviewAll 13F holders of VTYXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −6,484,558−100.0% | Sold out | Holders |
| Q4 2025 | 6,484,558 | $58.6M | 4.2% | +2,560,143+65.2% | Added | Holders |
| Q3 2025 | 3,924,415 | $12.2M | 1.1% | −611,767−13.5% | Reduced | Holders |
| Q2 2025 | 4,536,182 | $9.71M | 1.4% | +4,536,182 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −100,696−100.0% | Sold out | Holders |
| Q2 2023 | 100,696 | $3.30M | 1.3% | −159,312−61.3% | Reduced | Holders |
| Q1 2023 | 260,008 | $8.71M | 3.3% | +19,385+8.1% | Added | Holders |
| Q4 2022 | 240,623 | $7.89M | 3.6% | +70,623+41.5% | Added | Holders |
| Q3 2022 | 170,000 | $5.93M | 2.7% | +170,000 | New | Holders |